معرفی
Marloes Duijm is a researcher at Erasmus MC in the Department of Radiotherapy, affiliated with Erasmus Universiteit Rotterdam. Her work is centered on advancing radiation therapy techniques for lung cancer, particularly through stereotactic body radiotherapy (SBRT).
Her research interests focus on improving clinical outcomes for patients with early-stage and centrally located lung tumors. She specializes in developing and validating prognostic models and nomograms to predict overall survival and treatment-related toxicities. Her work integrates clinical data with statistical modeling to personalize radiotherapy planning and improve patient stratification.
The recent publications of Marloes Duijm demonstrate a strong trend in radiation oncology, particularly in the application of SBRT for non-small cell lung cancer and ultra-central tumors. Her research emphasizes predictive modeling for survival and toxicity, leveraging large clinical datasets for external validation. These studies contribute significantly to evidence-based radiotherapy protocols.
Marloes Duijm has not been publicly recognized with any scientific awards based on the available information.
She completed her doctoral thesis in 2021 at Erasmus Universiteit Rotterdam, titled "Outcome and Toxicity Modelling after Stereotactic Radiotherapy of Central Lung Tumors." There is no mention of her advising students or receiving research grants in the provided texts.
While her research is closely tied to the Radiotherapy department at Erasmus MC, there is no explicit mention of her leading a lab or a dedicated research team. Her collaborative publications suggest active participation in a broader research network within the institution.